Petco Health & Wellness Company, Inc. - 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for Petco Health & Wellness Company, Inc. (Petco) for the thirteen and twenty-six weeks ended August 3, 2024. Petco operates as a pet health and wellness company with an omnichannel ecosystem comprising over 1,500 pet care centers in the U.S., Mexico, and Puerto Rico, alongside a digital channel. The company manages its business as a single reportable operating segment.
Key Financial Metrics
| Metric | 13 Weeks Ended Aug 3, 2024 | 26 Weeks Ended Aug 3, 2024 |
|---|---|---|
| Net Sales | $1.52 billion | $3.05 billion |
| Gross Profit | $580.7 million (38.1% margin) | $1.16 billion (38.0% margin) |
| Operating Income (Loss) | $2.5 million | $(14.3) million |
| Net Loss | $(24.8) million | $(71.3) million |
| Adjusted EBITDA | $83.5 million | $159.2 million |
| Free Cash Flow | N/A | $0.9 million |
| Cash and Equivalents | $127.6 million | $127.6 million |
| Total Debt (Term Loan) | $1.595 billion | $1.595 billion |
| ABL Availability | $527.6 million | $527.6 million |
Material Changes vs. Prior Period
- Revenue: Net sales decreased 0.5% year-over-year (YoY) for the quarter and 1.1% for the year-to-date (YTD). This was driven by a 4.7% decline in supplies and companion animals sales due to softening discretionary spend, partially offset by growth in consumables (+1.5%) and services (+3.1%).
- Profitability: Operating income declined significantly from $24.0 million in the prior year quarter to $2.5 million. The YTD period shifted from an operating income of $51.7 million to a loss of $14.3 million.
- Expenses: Selling, General, and Administrative (SG&A) expenses increased 1.6% YoY for the quarter, primarily due to higher payroll, fringe benefits, and depreciation, partially offset by lower stock compensation and advertising.
- Cash Flow: Net cash provided by operating activities decreased to $61.0 million for the YTD period compared to $134.3 million in the prior year, driven by lower sales and increased cash paid for inventory.
Guidance, Outlook, and Risks
Management Commentary: Management notes continued momentum in consumables and services but highlights a decrease in supplies and companion animals sales attributed to the macroeconomic environment. The company is focusing on customer retention, visit frequency, and basket size to improve comparable sales. Capital expenditures were reduced to balance investments with cash flow needs.
Risks and Contingencies:
- Macroeconomic Pressures: Inflation, interest rates, and supply chain constraints continue to impact consumer spending on discretionary items.
- Debt Obligations: The company carries significant debt ($1.595 billion Term Loan) with variable interest rates, though it has utilized interest rate caps and collars to mitigate exposure.
- Legal Proceedings: The company is subject to ordinary course litigation; management does not currently expect these to have a material adverse effect.
Unusual Items: The company recorded fixed asset and right-of-use asset impairment charges of $3.4 million for the quarter and $6.9 million YTD. There were no losses on debt extinguishment in the current period.
Investor Verification Checklist
- Discretionary Spend Trends: Verify the sustainability of the decline in supplies and companion animals sales versus the growth in consumables and services.
- Cost Management: Monitor SG&A expense ratios, specifically payroll and depreciation, to ensure they do not outpace revenue recovery.
- Liquidity Position: Confirm the utilization of the $581 million ABL Revolving Credit Facility and the impact of interest rate fluctuations on the $1.6 billion Term Loan.
- Capital Allocation: Assess the impact of reduced capital expenditures on future store openings and veterinary hospital build-outs.
- Impairment Risks: Review the assumptions used in goodwill and trade name impairment testing given the company's market capitalization relative to book value.